BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22459449)

  • 1. Characterization of Dkk1 gene regulation by the osteoblast-specific transcription factor Osx.
    Zhang C; Dai H; de Crombrugghe B
    Biochem Biophys Res Commun; 2012 Apr; 420(4):782-6. PubMed ID: 22459449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerostin is a direct target of osteoblast-specific transcription factor osterix.
    Yang F; Tang W; So S; de Crombrugghe B; Zhang C
    Biochem Biophys Res Commun; 2010 Oct; 400(4):684-8. PubMed ID: 20816666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoblast-specific transcription factor Osterix (Osx) is an upstream regulator of Satb2 during bone formation.
    Tang W; Li Y; Osimiri L; Zhang C
    J Biol Chem; 2011 Sep; 286(38):32995-3002. PubMed ID: 21828043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase 13 (MMP13) is a direct target of osteoblast-specific transcription factor osterix (Osx) in osteoblasts.
    Zhang C; Tang W; Li Y
    PLoS One; 2012; 7(11):e50525. PubMed ID: 23185634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of bone sialoprotein gene expression by Osx.
    Yang Y; Huang Y; Zhang L; Zhang C
    Biochem Biophys Res Commun; 2016 Aug; 476(4):574-579. PubMed ID: 27261434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblast-specific transcription factor Osterix increases vitamin D receptor gene expression in osteoblasts.
    Zhang C; Tang W; Li Y; Yang F; Dowd DR; MacDonald PN
    PLoS One; 2011; 6(10):e26504. PubMed ID: 22028889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix.
    Zhang C; Cho K; Huang Y; Lyons JP; Zhou X; Sinha K; McCrea PD; de Crombrugghe B
    Proc Natl Acad Sci U S A; 2008 May; 105(19):6936-41. PubMed ID: 18458345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of Vascular Endothelial Growth Factor (VEGF) by osteoblast-specific transcription factor Osterix (Osx) in osteoblasts.
    Tang W; Yang F; Li Y; de Crombrugghe B; Jiao H; Xiao G; Zhang C
    J Biol Chem; 2012 Jan; 287(3):1671-8. PubMed ID: 22110141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic inhibition of Wnt pathway by HIF-1α and osteoblast-specific transcription factor osterix (Osx) in osteoblasts.
    Chen D; Li Y; Zhou Z; Xing Y; Zhong Y; Zou X; Tian W; Zhang C
    PLoS One; 2012; 7(12):e52948. PubMed ID: 23300831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblast-specific transcription factor Osterix (Osx) and HIF-1α cooperatively regulate gene expression of vascular endothelial growth factor (VEGF).
    Chen D; Tian W; Li Y; Tang W; Zhang C
    Biochem Biophys Res Commun; 2012 Jul; 424(1):176-81. PubMed ID: 22750006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osterix controls cementoblast differentiation through downregulation of Wnt-signaling via enhancing DKK1 expression.
    Cao Z; Liu R; Zhang H; Liao H; Zhang Y; Hinton RJ; Feng JQ
    Int J Biol Sci; 2015; 11(3):335-44. PubMed ID: 25678852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The muscle transcription factor MyoD promotes osteoblast differentiation by stimulation of the Osterix promoter.
    Hewitt J; Lu X; Gilbert L; Nanes MS
    Endocrinology; 2008 Jul; 149(7):3698-707. PubMed ID: 18372333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiation.
    Lu X; Beck GR; Gilbert LC; Camalier CE; Bateman NW; Hood BL; Conrads TP; Kern MJ; You S; Chen H; Nanes MS
    J Bone Miner Res; 2011 Jan; 26(1):209-19. PubMed ID: 20683885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the osterix (Osx, Sp7) promoter by osterix and its inhibition by parathyroid hormone.
    Barbuto R; Mitchell J
    J Mol Endocrinol; 2013; 51(1):99-108. PubMed ID: 23682129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osterix and NO66 histone demethylase control the chromatin of Osterix target genes during osteoblast differentiation.
    Sinha KM; Yasuda H; Zhou X; deCrombrugghe B
    J Bone Miner Res; 2014 Apr; 29(4):855-65. PubMed ID: 24115157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of C-terminal Hsp70-interacting protein as a mediator of tumour necrosis factor action in osteoblast differentiation by targeting osterix for degradation.
    Xie J; Gu J
    J Cell Mol Med; 2015 Aug; 19(8):1814-24. PubMed ID: 25818514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways.
    Lu X; Gilbert L; He X; Rubin J; Nanes MS
    J Biol Chem; 2006 Mar; 281(10):6297-306. PubMed ID: 16410254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of osteoblast-specific transcription factor Osterix effect on bone formation.
    Zhang C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):659-65. PubMed ID: 23073571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase.
    Sinha KM; Yasuda H; Coombes MM; Dent SY; de Crombrugghe B
    EMBO J; 2010 Jan; 29(1):68-79. PubMed ID: 19927124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.